United States News All stories

Honeywell (NASDAQ:HON) announced on Monday, April 27, 2026, that its Board of Directors has declared a quarterly dividend of $1.19 per share.

Linde (NASDAQ:LIN) announced on Monday, April 27, 2026, that its Board of Directors has declared a quarterly dividend of $1.60 per share.

Oruka Therapeutics (NASDAQ:ORKA) announced positive interim results from its EVERLAST-A Phase 2a trial on Monday, April 27, 2026.

Noble (NYSE:NE) reported strong financial and operational results for the first quarter of 2026 on Monday, highlighting a sequential increase in both revenue and profitability.

Ligand Pharmaceuticals (NASDAQ:LGND) announced on Monday, April 27, 2026, that it has entered into a definitive agreement to acquire XOMA Royalty for $39 per share in cash.

The Real Brokerage (NASDAQ:REAX) and RE/MAX Holdings (NYSE:RMAX) announced on Monday, April 27, 2026, a definitive agreement for Real to acquire RE/MAX Holdings.

Clearmind Medicine (NASDAQ:CMND) announced on Monday, April 27, 2026, that it is evaluating its lead drug candidate, CMND-100 (MEAI), for a potential FDA Breakthrough Therapy Designation (BTD).

Shell (NYSE:SHEL) announced on Monday, April 27, 2026, that it has reached a definitive agreement to acquire Canadian energy leader ARC Resources in a transaction valued at approximately $16.4 billion, including debt.

Sierra Bancorp (NASDAQ:BSRR), the parent company of Bank of the Sierra, announced strong unaudited financial results for the first quarter of 2026 on Monday, reporting a 47% increase in diluted earnings per share compared to the same period last year.

Repay Holdings (NASDAQ:RPAY) released preliminary, unaudited financial results for the first quarter of 2026 on Monday, April 27, while simultaneously raising its full-year profitability outlook.

Business First Bancshares (NASDAQ:BFST), the parent company of b1BANK, reported its first-quarter 2026 financial results on Monday, highlighting a period of significant expansion following its recent merger activity.

Bank of Marin Bancorp (NASDAQ:BMRC) reported a strong return to profitability for the first quarter of 2026 on Monday, posting net income of $8.5 million.

Johnson & Johnson (NYSE:JNJ) announced on Monday that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY (nipocalimab-aahu).

AbbVie (NYSE:ABBV) announced on Monday, April 27, 2026, that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for SKYRIZI (risankizumab-rzaa).

Norwood Financial (NASDAQ:NWFL), the parent company of Wayne Bank, announced its financial results for the first quarter of 2026 on Monday, a period defined by the successful closing and integration of Presence Bancshares.

Thermo Fisher Scientific (NYSE:TMO) announced on Monday that it has entered into a definitive agreement to sell its microbiology business to Astorg, a prominent pan-European private equity firm.

Jazz Pharmaceuticals (NASDAQ:JAZZ) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its supplemental Biologics License Application (sBLA) for Ziihera (zanidatamab-hrii).

CorMedix (NASDAQ:CRMD) announced positive topline results on Monday from the global Phase III ReSPECT trial evaluating REZZAYO (rezafungin) for the prevention of invasive fungal diseases in adult allogeneic hematopoietic stem cell transplant (HSCT) patients.

Alterity Therapeutics (NASDAQ:ATHE) announced on Monday that it has received positive written feedback from the U.S. Food and Drug Administration (FDA) following a second Type C meeting regarding its ATH434 Phase 3 program.

Intellia Therapeutics (NASDAQ:NTLA) today announced positive topline results from its pivotal Phase 3 HAELO clinical trial evaluating lonvoguran ziclumeran (lonvo-z), a one-time in vivo CRISPR-based gene editing therapy for patients with hereditary angioedema (HAE).

Purple Biotech (NASDAQ:PPBT) released promising preclinical data on Monday for its lead therapeutic candidate, IM1240, demonstrating consistent anti-tumor activity across seven distinct patient-derived tumor samples.

HBT Financial (NASDAQ:HBT) reported its first-quarter 2026 financial results on Monday, highlighting a transformative period following the completion of its acquisition of CNB Bank shares.

Lakeland Financial (NASDAQ:LKFN), the parent company of Lake City Bank, reported record-breaking financial results for the first quarter of 2026 on Monday.

Alliance Resource Partners (NASDAQ:ARLP) reported its financial and operating results for the first quarter of 2026 on Monday, characterized by record-breaking performance in its royalty segments despite pricing challenges in the coal market.